Dejan Muftic, Commercial Obesity Portfolio Lead at Novo Nordisk

Dejan Muftic

Commercial Obesity Portfolio Lead at Novo Nordisk | Copenhagen, Capital Region of Denmark, Denmark

Profile last verified October 2026
Pharmaceuticals Verified Profile Copenhagen, Capital Region of Denmark, Denmark Stockholm School of Economics
Verified

Personal Email

***@gmail.com

Personal • High Confidence

Phone Number

(**) *** *** 162

Denmark • Phone

Free account · No credit card · 5 profiles/month

Dejan Muftic Socials
Dejan Muftic Work Experience

Commercial Obesity Portfolio Lead at Novo Nordisk in May 2023 - Present

Senior Global Project Manager at Novo Nordisk in January 2018 - May 2023

Global Product Manager at Novo Nordisk in August 2016 - January 2018

See more See less

Business Management Graduate at Novo Nordisk in September 2014 - August 2016

Founder at dMa Nordic AB in January 2009 - August 2014

Summer Analyst at Torreya in June 2013 - July 2013

Research Assistant at Karolinska Institutet in January 2011 - August 2011

Campus Representative at Apple in September 2006 - May 2011

Sales Associate at Macoteket AB in January 2010 - July 2010

Dejan Muftic Education

Stockholm School of Economics, Master of Science (MS), November 2026

National University of Singapore

Leiden University

See more See less

Karolinska Institutet, Master of Science (M.Sc.), November 2026

Dejan Muftic Skills
New Product Planning Portfolio Strategy Due Diligence Business Case Development Financial Modeling Target Product Profile (TPP) Competitive Intelligence Stakeholder Management Microsoft Office Research Time Management Microsoft Excel Sales Teamwork Data Analysis Analysis Management Consulting Leadership Management Project Management Analytical Skills Business Strategy Strategy
About Dejan Muftic’s Current Company
Novo Nordisk

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Discover more about Novo Nordisk
Dejan Muftic’s Colleagues
Tore Veum

Tore Veum

Norway

Global Director Frontline Excellence Rare Diseases, Novo Nordisk

Owner at Veum Consulting
(March 2015 – Present)

Naheel Korfiatis

Naheel Korfiatis

Dubai, United Arab Emirates

PMP® | Regulatory Affairs Project Lead (Business Area Middle East, Affrica & CIS) at Novo Nordisk

Regulatory Affairs Project Lead (Business Area Middle East, Africa &CIS) at Novo Nordisk
(January 2024 – Present)

Karleen Rush

Karleen Rush

Raleigh-Durham-Chapel Hill Area

Medical Science Liaison, Diabetes & Renal

Wine Rep at ONEHOPE Wine
(June 2021 – Present)

Gaetano Gati

Gaetano Gati

Rome, Latium, Italy

Public Affairs Manager presso Novo Nordisk

Public Affairs Manager at Novo Nordisk
(May 2022 – Present)

Diego Bacelic

Diego Bacelic

Toronto, Ontario, Canada

Obesity Market Access | Novo Nordisk Canada

Consultant at Global Market Access Solutions
(May 2026 – May 2026)

Anne Preskou

Anne Preskou

Copenhagen, Capital Region of Denmark, Denmark

Associate Director – Novo Nordisk

Student in Business Partner Operation Nordic (BPO) at IBM
(January 2006 – May 2026)

Search similar profiles
Frequently asked questions about Dejan Muftic

What is Dejan Muftic email address?

Email Dejan Muftic at [email protected] and [email protected]. This email is the most updated Dejan Muftic's email found in 2026.

How to contact Dejan Muftic?

To contact Dejan Muftic send an email to [email protected] or [email protected]. (updated on April 16, 2026)

What company does Dejan Muftic work for?

Dejan Muftic works for Novo Nordisk.

What is Dejan Muftic's role at Novo Nordisk?

Dejan Muftic is Commercial Obesity Portfolio Lead

What industry does Dejan Muftic work in?

Dejan Muftic works in the Pharmaceuticals industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free